Abicipar Holds Potential As Long Acting Treatment In Neovascular AMD: Study
A new study on longer-acting treatment for wet macular degeneration By Medha USA: Abicipar was shown to have a longer duration of effect in patients with treatment-naive neovascular age-related macular…